9.955
Schlusskurs vom Vortag:
$10.24
Offen:
$10.3
24-Stunden-Volumen:
2.75M
Relative Volume:
0.70
Marktkapitalisierung:
$2.59B
Einnahmen:
$6.29B
Nettoeinkommen (Verlust:
$750.00M
KGV:
3.4566
EPS:
2.88
Netto-Cashflow:
$586.00M
1W Leistung:
-9.05%
1M Leistung:
-4.05%
6M Leistung:
-21.28%
1J Leistung:
-44.82%
Organon Co Stock (OGN) Company Profile
Firmenname
Organon Co
Sektor
Telefon
551-430-6000
Adresse
30 HUDSON STREET, JERSEY CITY
Vergleichen Sie OGN mit anderen Aktien
Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
---|---|---|---|---|---|---|
![]()
OGN
Organon Co
|
9.955 | 2.66B | 6.29B | 750.00M | 586.00M | 2.88 |
![]()
LLY
Lilly Eli Co
|
853.96 | 758.15B | 53.26B | 13.80B | -50.20M | 15.08 |
![]()
JNJ
Johnson Johnson
|
190.88 | 456.84B | 90.62B | 22.66B | 18.18B | 9.35 |
![]()
ABBV
Abbvie Inc
|
231.31 | 408.50B | 58.33B | 3.73B | 18.24B | 2.1013 |
![]()
NVS
Novartis Ag Adr
|
131.38 | 256.13B | 53.40B | 13.68B | 16.89B | 6.8864 |
![]()
MRK
Merck Co Inc
|
87.32 | 215.81B | 63.43B | 16.42B | 14.72B | 6.4861 |
Organon Co Stock (OGN) Upgrades & Downgrades
Datum | Aktion | Analytiker | Ratingänderung |
---|---|---|---|
2025-05-02 | Herabstufung | Evercore ISI | Outperform → In-line |
2024-09-06 | Herabstufung | JP Morgan | Neutral → Underweight |
2023-11-03 | Herabstufung | Goldman | Buy → Neutral |
2023-09-21 | Eingeleitet | Barclays | Overweight |
2023-03-16 | Eingeleitet | Raymond James | Outperform |
2022-10-14 | Herabstufung | BofA Securities | Neutral → Underperform |
2022-09-06 | Hochstufung | Piper Sandler | Neutral → Overweight |
2022-08-05 | Herabstufung | BofA Securities | Buy → Neutral |
2022-04-27 | Eingeleitet | Goldman | Buy |
2022-04-06 | Fortgesetzt | Morgan Stanley | Equal-Weight |
2021-10-07 | Eingeleitet | Piper Sandler | Neutral |
2021-09-01 | Eingeleitet | BofA Securities | Buy |
2021-07-22 | Eingeleitet | Citigroup | Buy |
2021-06-15 | Eingeleitet | JP Morgan | Neutral |
2021-06-11 | Eingeleitet | Morgan Stanley | Equal-Weight |
2021-06-10 | Eingeleitet | Evercore ISI | Outperform |
Alle ansehen
Organon Co Aktie (OGN) Neueste Nachrichten
Q2 Earnings Highs And Lows: Organon (NYSE:OGN) Vs The Rest Of The Branded Pharmaceuticals Stocks - FinancialContent
Is There Now Opportunity in Organon Stock After Recent Double Digit Drop in 2025? - Yahoo
Investors Heavily Search Organon & Co. (OGN): Here is What You Need to Know - Yahoo Finance
Is Organon a Hidden Bargain After Shares Drop Nearly 40% in 2024? - simplywall.st
Organon (OGN) Stock Slides as Market Rises: Facts to Know Before You Trade - sharewise.com
Will Organon (OGN) Beat Estimates Again in Its Next Earnings Report? - sharewise.com
Is Organon (NYSE:OGN) A Risky Investment? - 富途牛牛
Is Organon Co a good long term investmentInterest Rate Changes & Advanced Stock Screening Tools - earlytimes.in
3 Reasons To Avoid OGN And 1 Stock To Buy Instead - Barchart.com
User - FinancialContent
Organon (NYSE:OGN) Has No Shortage Of Debt - 富途牛牛
Organon & Co trades in the red for seven straight sessions - MSN
Organon & Co. (NYSE:OGN) Receives Average Rating of "Moderate Buy" from Analysts - MarketBeat
Co. (7XP) stock good for long term investingJuly 2025 Big Picture & High Accuracy Trade Signal Alerts - newser.com
Organon & Co. $OGN Shares Acquired by Cantor Fitzgerald Investment Advisors L.P. - MarketBeat
Organon & Co. $OGN Shares Purchased by State of Alaska Department of Revenue - MarketBeat
AbbVie, AMN Healthcare Services, LeMaitre, Waters Corporation, and Organon Shares Skyrocket, What You Need To Know - Yahoo
Organon (OGN) Shares Skyrocket, What You Need To Know - MSN
Co. (7XP) stock in 2025Quarterly Profit Review & Community Driven Trade Alerts - newser.com
Organon & Co. $OGN Stake Lessened by Sound Income Strategies LLC - MarketBeat
Dakota Wealth Management Has $151,000 Stock Position in Organon & Co. $OGN - MarketBeat
Co. (7XP) stock considered safe havenPortfolio Return Report & AI Enhanced Execution Alerts - newser.com
Organon (OGN) Outperforms Broader Market: What You Need to Know - sharewise.com
What analysts say about Organon Co stockReal-Time Stock Alerts & High Return Stock Ideas - Early Times
Sterneck Capital Management LLC Makes New Investment in Organon & Co. $OGN - MarketBeat
Register Financial Advisors LLC Sells 30,706 Shares of Organon & Co. $OGN - MarketBeat
Organon partners across Asia Pacific to push equitable access to contraception ahead of World Contraception Day - MediaBrief
Here's Why Organon (OGN) Fell More Than Broader Market - sharewise.com
Here is What to Know Beyond Why Organon & Co. (OGN) is a Trending Stock - sharewise.com
Organon & Co. Experiences Revision in Stock Evaluation Amid Market Dynamics - Markets Mojo
Wedmont Private Capital Acquires 106,561 Shares of Organon & Co. $OGN - MarketBeat
Organon (OGN): Examining Valuation Following European Approval of Denosumab Biosimilars - simplywall.st
Organon announces departure of chief commercial officer - MSN
Gilman Hill Asset Management LLC Sells 443,231 Shares of Organon & Co. $OGN - MarketBeat
Triumph Capital Management Acquires 47,127 Shares of Organon & Co. $OGN - MarketBeat
Organon (OGN) Stock Dips While Market Gains: Key Facts - sharewise.com
Organon gets EU approval for Prolia and Xgeva biosimilars - MSN
Douglas Lane & Associates LLC Raises Holdings in Organon & Co. $OGN - MarketBeat
Organon Q2 Preview: What to expect? - MSN
Ocugen gets EU approval for Prolia and Xgeva biosimilars - MSN
Organon (OGN) Gains EU Approval for Denosumab Biosimilars - GuruFocus
Organon gets EU approval for Prolia and Xgeva biosimilars (OGN:NYSE) - Seeking Alpha
Organon, Shanghai Henlius: EC approves marketing for Bildyos, Bilprevda - TipRanks
(denosumab), Biosimilars to PROLIA (denosumab) and XGEVA (denosumab), Respectively - Business Wire
Belpointe Asset Management LLC Buys New Stake in Organon & Co. $OGN - MarketBeat
Finanzdaten der Organon Co-Aktie (OGN)
Umsatz
Nettogewinn
Free Cashflow
ENV
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):